Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 53:1021-1030, doi:10.1016/j.jacc.2008.12.021
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Get Go to quiz for this Article
Right arrow View Related Cardiosource Journal Scan
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopes, R. D.
Right arrow Articles by Ohman, E. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lopes, R. D.
Right arrow Articles by Ohman, E. M.
Related Collections
Right arrowRelated Article

Advanced Age, Antithrombotic Strategy, and Bleeding in Non–ST-Segment Elevation Acute Coronary Syndromes

Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial

Renato D. Lopes, MD, PhD*,*, Karen P. Alexander, MD*, Steven V. Manoukian, MD{dagger}, Michel E. Bertrand, MD{ddagger}, Frederick Feit, MD§, Harvey D. White, MD||, Charles V. Pollack, Jr, MD, MA, James Hoekstra, MD#, Bernard J. Gersh, MB, ChB, DPhil**, Gregg W. Stone, MD{dagger}{dagger} and E. Magnus Ohman, MD*

* Duke University Medical Center, Durham, North Carolina
{dagger} The Sarah Cannon Research Institute and Centennial Heart Center, Nashville, Tennessee
{ddagger} Hopital Cardiologique, Lille, France
§ New York University School of Medicine, New York, New York
|| Auckland City Hospital, Auckland, New Zealand
Pennsylvania Hospital, Philadelphia, Pennsylvania
# Wake Forest University, Winston-Salem, North Carolina
** Mayo Clinic, Rochester, Minnesota
{dagger}{dagger} Columbia University Medical Center, and The Cardiovascular Research Foundation, New York, New York


Figure 1
View larger version (19K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 NNT With Bivalirudin Alone Versus Heparin Plus GP IIb/IIIa Inhibitors to Avoid 1 Non-CABG Major Bleeding Event

Data shown by age group and antithrombotic strategy. (A) The number needed to treat (NNT) overall. (B) The NNT among percutaneous coronary intervention-treated patients. CABG = coronary artery bypass graft; GPI = glycoprotein inhibitor.

 

Figure 2
View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 NNT With Bivalirudin Alone Versus Heparin Plus GP IIb/IIIa Inhibitors to Avoid 1 Non-CABG Major Bleeding Event Among Patients Without Excess Dose

Data shown by age group and antithrombotic strategy after excluding patients who received excess dose of antithrombotic therapies (n = 436) based on renal function. (A) The NNT overall. (B) The NNT among percutaneous coronary intervention-treated patients. Abbreviations as in Figure 1.

 

Figure 3
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Mortality Rates Among Patients With and Without ACUITY Non-CABG Major Bleeding

Data shown by age group. (A) Rates of 30-day mortality. (B) Rates of 1-year mortality. ACUITY = Acute Catheterization and Urgent Intervention Triage Strategy; other abbreviations as in Figure 1.

 




 
  CME Topic Collections Past Issues Search Current Issue Home